The t(6;9)(p22;q34) in myeloid neoplasms: A retrospective study of 16 cases

Cancer Genetics and Cytogenetics

Volumn 203, Issue 2, 2010, Pages 297-302

  Gupta, Monika ^a   Ashok Kumar, J ^a   Sitaram, Usha ^a   Neeraj, S ^a   Nancy, A ^a   Balasubramanian, Poonkuzhali ^a   Abraham, Aby ^a   Mathews, Vikram ^a   Viswabandya, Auro ^a   George, Biju ^a   Chandy, Mammen ^a   Srivastava, Alok ^a   Srivastava, Vivi M ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD135 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CHILD; CHROMOSOME 13; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ADDITION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE DUPLICATION; GENE EXPRESSION; HUMAN; ISOCHROMOSOME; MALE; MAST CELL LEUKEMIA; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650033019     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.08.012     Document Type: Article

References (23)

1. Slovak M.L., Gundacker H., Bloomfield C.D., Dewald G., Appelbaum F.R., Larson R.A., et al. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. Leukemia 2006, 20:1295-1297.
2. Soekarman D., Von Lindem M., Daenen S., De Jong B., Fonatsch C., Heinze B., et al. The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992, 79:2990-2997.
3. Cuneo A., Kerim S., Vandenberghe E., Van Orshoven A., Rodhain J., Bosly A., et al. Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement. Cancer Genet Cytogenet 1989, 42:209-219.
4. Shapira M.Y., Hirshberg B., Amir G., Rund D. 6;9 translocation in myelodysplastic syndrome. Cancer Genet Cytogenet 1999, 112:57-59.
5. Fleischman E.W., Prigogina E., Iljinskaja G.W., Konstantinova L.N., Puchkova G.P., Volkova M.A., et al. Chromosomal rearrangements with a common breakpoint at 6p23 in five cases of myeloid leukemia. Hum Genet 1983, 64:254-256.
6. Chi Y., Lindgren V., Quigley S., Gaitonde S. Acute myelogenous leukemia with t(6 ;9)(p23 ;q34) and marrow basophilia. Arch Pathol Lab Med 2008, 132:1835-1837.
7. Pearson M.G., Vardiman J.W., Le Beau M.M., Rowley J.D., Schwartz S., Kerman S.L., et al. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. Am J Hematol 1985, 18:393-403.
8. Horsman D.E., Kalousek D.K. Acute myelomonocytic leukemia (AML- M4) and translocation t(6;9)(p23;q34): two additional patients with prominent myelodysplasia. Am J Hematol 1987, 26:77-82.
9. Oyarzo M.P., Lin P., Glassman A., Bueso-Ramos C.E., Luthra R., Medeiros L.J. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol 2004, 122:348-358.
10. Von Lindern M., Poustka A., Lerach H., Grosveld G. The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol 1990, 10:4016-4026.
11. Hamaguchi H., Nagata K., Yamamoto K., Fujikawa I., Kobayashi M., Eguchi M. Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript. Br J Haematol 1998, 102:1249-1256.
12. Korf B.R. Cancer genetics. Current Protocols In Human Genetics 1994, 10.2.1-10.2.2. John Wiley & Sons, New York. N.C. Dracopoli, J.L. Haines, B.R. Korf, D.T. Moir, C.C. Morton, C.E. Seidman (Eds.).
13. ISCN. An International System of Human Cytogenetic Nomenclature 2005, S. Karger, Basel. L.G. Shaffer, N. Tommerup (Eds.).
14. Amorim M.R., Vargas F.R., Llerena J.C., Pombo-de Oliveira M.S. DNA extraction from fixed cytogenetic cell suspensions. Genet Mol Res 2007, 6:500-503.
15. Yamamoto Y., Kiyoi H., Nakano Y., Suzuki R., Kodera Y., Miyawaki S., et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001, 97:2434-2439.
16. Huang Q., Chen W., Gaal K.K., Slovak M.L., Stein A., Weiss L.M. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics. Br J Haematol 2008, 142:489-492.
17. Rowley J.D., Potter D. Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976, 47:705-721.
18. Alsabeh R., Brynes R.K., Slovak M.L., Arber D.A. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol 1997, 107:430-437.
19. Lillington D.M., Mac Callum P.K., Lister T.A., Gibbons B. Translocation (6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature. Leukemia 1993, 7:527-531.
20. Fan Y.S., Raza A., Schumer J., Sait S.N.J., Block A.M.W., Synderman M., et al. Translocation t(6;9)(p22.3;q34) in myelodysplastic syndrome: refractory anemia with excess blasts. Cancer Genet Cytogenet 1987, 29:135-138.
21. Levin M., Le Coniat M., Bernheim A., Berger R. Complex chromosomal abnormalities in acute nonlymphocytic leukaemia. Cancer Genet Cytogenet 1987, 26:363.
22. Yoshimoto G., Nagafuji K., Miyamoto T., Kinukawa N., Takase K., Eto T., et al. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2005, 36:977-983.
23. Vardiman J.W., Burnning R.D., Arber D.A., Le Beau M.M., Porwit A., Tefferi A., et al. Introduction and overview of the classification of the myeloid neoplasms. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 18-30. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein (Eds.).